Dr. Lukasz Robert Kiljanek, MD

Dr. Kiljanek practices at Hoskinson Health & Wellness Clinic in Gillette, Wyoming.

Dr. Kiljanek's NPI, 1770739641, was assigned on August 12, 2008. Dr. Kiljanek graduated from Medical University of Warsaw in 2005. Dr. Kiljanek holds Wyoming license TL8345.

Dr. Kiljanek's primary practice is Hoskinson Health & Wellness Clinic, at 469 Hwy 50, Gillette, WY 82718 in Campbell County. The practice phone is (307) 387-9850.

Dr. Kiljanek's primary practice is Hoskinson Health & Wellness Clinic in Gillette, Wyoming. Dr. Kiljanek is also affiliated with Campbell County Memorial Hospital. The medical group on file is Hoskinson Health and Wellness Clinic. Dmand AI also links Dr. Kiljanek to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kiljanek practices, 4 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Kiljanek's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Kiljanek is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Kiljanek's licenses on file in 3 states: Wyoming, Maryland and Pennsylvania.

Dmand AI lists acute kidney failure, acute skin infection, aneurysm, asthma, cerebrovascular disease, chronic anemia, chronic diabetes and chronic hypertension among the conditions Dr. Kiljanek treats.

CMS data shows 1,558 Medicare services from Dr. Kiljanek across 13 procedure codes in 2024, for 334 Medicare patients. Medicare paid $93,536 for them. Every service was in an office.

CMS counts 334 Medicare patients who saw Dr. Kiljanek in 2024. The largest group is 65 to 74, with 131 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kiljanek's median patient age at 66, with 49% women.

In 2024, Dr. Kiljanek wrote 1,713 Medicare Part D claims for 305 patients. 88% of them were for generic drugs. CMS names the drug for 1,438 of them, across 22 drugs with 11 or more claims each, at $261,850 in total drug cost. In 2023, CMS named 1,397 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Kiljanek for performance year 2024, reported as part of a group. Dr. Kiljanek accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Kiljanek, published from 2012 to 2014. 2012 was the busiest year, with 2. The most frequent topics are Coronary Artery Bypass, Off-Pump and Coronary Artery Disease. Dr. Kiljanek's most frequent co-authors are William B. Bachinsky, MD, Bravein Amalakuhan, MD and Arvin Parvathaneni, MD.

CMS Open Payments shows 16 general payments to Dr. Kiljanek from 11 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 79% of the total. Relypsa, Inc. paid the most, $103.

Dr. Kiljanek graduated from Medical University of Warsaw in 2005.

Dr. Kiljanek is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.